gestational diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Outpatients who meet all of the following criteria can be enrolled in this study; 1. patients diagnosed with gestational diabetes mellitus at the Department of Endocrinology and Diabetes, Saitama Medical University Hospital, who are treated with diet and exercise therapy alone or with insulin preparations in addition to diet and exercise therapy 2. patients who are 18 years of age or older at giving their consent 3. patients with a pregnancy between 5 and 28 weeks at giving their consent 4. Patients with HbA1c of 6.4% or less at giving their consent 5. If the patients use insulin, patients who have not changed their insulin dose from 4 weeks prior to the date of consent until the date of consent 6. Patients who give ther consent by written form to participate in this study
Exclusion criteria
Exclusion criteria: Patients who fall into any of the following criteria at giving their consent are excluded from participating in this study; 1. Patients obviously diagnosed with diabetes mellitus during pregnancy or diabetic complicated pregnancy 2. Patients using anti-diabetic agents other than insulin 3. Patients obviously diagnosed with pregnancy-induced hypertension 4. Patients using medical agents known to induce abnormal glucose metabolism (psychotropic drugs, corticosteroids, etc.) or suffering from diseases causing secondary diabetes (Cushing's syndrome, primary aldosteronism, endocrine disorders such as hyperthyroidism, liver cirrhosis, chronic pancreatitis, etc.) 5. Patients with possible food allergies to any of the components (e.g., flour, egg, milk, soy, fish meat, etc.) of the study food. 6. Patients with other conditions that the investigator thinks unsuitable for participating in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Although this study will compare the transition of glucose levels obtained by CGM in the three times daily diet and the six times daily split-meal diet, there are no papers in which the Time in range (TIR), one of the major indexes of CGM and the primary endpoint in this study, was calculated in the six times daily split-meal diet. Therefore, the primary endpoint will be the mean value and 95% confidence interval of the TIR calculated from the transition of glucose levels measured by CGM over 24 hours in the six times daily split-meal diet. | — |
Secondary
| Measure | Time frame |
|---|---|
| Step 1: Effect of snacking foods on blood glucose levels: - The maximum change in blood glucose level from baseline (30 minutes before consumption) to within 2 hours after consumption of each food, measured by CGM. - Time of the maximum change in blood glucose levels from baseline (30 minutes before consumption) to within 2 hours after consumption of each food, measured by CGM. - AUC of blood glucose levels from baseline (30 minutes before consumption) to within 2 hours after consumption of each food, measured by CGM. - preference questionnaire Step 2: Efficacy of split-meals: - Trends in glucose levels over 24 hours as measured by CGM during the study period comparing the normal diet (3 meals per day) and the six times split meals diet - % time in range (TIR), which is the time in the range of 72 to 140 mg/dL, - % time below range (TBR), which is the time of 140 mg/dL - mean glucose value - fluctuation of glucose level (coefficient of variation / CV) - the maximum glucose level in 24 hours during the comparison study - the minimum glucose level in 24 hours during the comparison study | — |
Contacts
Saitama Medical University Hospital